交易中 12-24 10:11:49 美东时间
+0.855
+1.44%
Shares of broader consumer discretionary stocks are trading higher. Softer-than...
12-19 04:03
The final session of the week saw red dominate Wall Street screens, as stocks slid broadly following a renewed tech-led sell-off.
12-13 01:27
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Truist Securities analyst Jake Bartlett initiates coverage on Cava Group (NYSE:CAVA) with a Buy rating and announces Price Target of $66.
12-05 00:03
Shares of broader consumer discretionary stocks are trading lower amid overall ...
11-21 03:40
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
Argus Research analyst Christine Dooley maintains Cava Group (NYSE:CAVA) with a Buy and lowers the price target from $76 to $60.
11-13 23:09
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价;Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
TD Cowen analyst Andrew M. Charles maintains Cava Group (NYSE:CAVA) with a Buy and lowers the price target from $80 to $67.
11-05 18:39